Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors Meeting Abstract


Authors: Gu, S.; Dusza, S. W.; Dunkel, I. J.; Drilon, A. E.; Lacouture, M. E.; Markova, A.
Abstract Title: Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.3143
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 3143 -- This meeting was also held virtually -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Ira J Dunkel
    371 Dunkel
  3. Stephen Dusza
    288 Dusza
  4. Alexander Edward Drilon
    632 Drilon
  5. Alina Markova
    87 Markova
  6. Stephanie Gu
    15 Gu